<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00375141</url>
  </required_header>
  <id_info>
    <org_study_id>KF-01-316279</org_study_id>
    <nct_id>NCT00375141</nct_id>
  </id_info>
  <brief_title>Long-Pulsed Dye Laser and Intense Pulsed Light for Skin Rejuvenation.</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bispebjerg Hospital</source>
  <brief_summary>
    <textblock>
      The purpose of the trial is to compare clinical efficacy and occurrence of side effects in
      the treatment of photodamaged skin with Pulsed Dye Laser and Intense Pulsed Light.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Inclusion, treatments and follow-up are finished
  </why_stopped>
  <completion_date type="Actual">May 2007</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>Single</masking>
  </study_design_info>
  <condition>Photodamaged Skin</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pulsed dye laser, Intense pulsed light</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Mild to moderate bilateral facial photodamage

          -  Symmetry in the facial area of wrinkles, skin texture, pigmentary changes and
             telangiectasia

          -  Fitzpatrick’s skin type of Type I, II, or III, without significant tan

          -  Age &gt; 40 years

          -  Able to read and comprehend Danish

          -  Informed consent agreement signed by the subject

          -  Willingness to follow the treatment schedule and posttreatment follow-up evaluations

          -  Willingness to allow photographs of the treated area to be taken for evaluation of
             efficacy.

        Exclusion Criteria:

          -  Scarring or infection of the area to be treated

          -  Known photosensitivity

          -  Presence of a suntan in the area to be treated

          -  Subjects taken medication known to induce photosensitivity in the previous three
             months

          -  Known anticoagulation or thromboembolic conditions

          -  Subjects taking anticoagulation medication

          -  Subjects taking Accutane within the past 6 months

          -  Subjects treated with aspirins or anti-inflammatory drugs

          -  Subjects who are immunocompromised or have a medical history that is inappropriate for
             the study per the investigator’s clinical judgment.

          -  Dermabrasion, chemical peel, laser or IPL treatment, or collagen injection therapy in
             the facial area in the past 12 months.

          -  Previous formation of hypertrophic scars or keloids

          -  Subjects who are pregnant or lactating

          -  Asymmetry in the facial area of wrinkles, skin texture, pigmentary changes and
             telangiectasia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Merete Hædersdal</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bispebjerg Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bispebjerg Hospital</name>
      <address>
        <city>Copenhagen</city>
        <zip>NV</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>June 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 11, 2006</study_first_submitted>
  <study_first_submitted_qc>September 11, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2006</study_first_posted>
  <last_update_submitted>June 4, 2007</last_update_submitted>
  <last_update_submitted_qc>June 4, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 6, 2007</last_update_posted>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

